The high hype around AI is still here. AI has hit us with the rush of a technology trigger and big expectations, and we could be on the verge of dropping into the trough of disillusionment. The smartest move in this situation is to bend the curve. This is what this on-demand webinar is about. Be agile and flexible in your innovation, join collaborations with tangible MVPs, and move fast into the future of AI applications.' You can watch the webinar recording here: https://lnkd.in/dZNy7-Kb #ai #artificialintelligence #pharma #webinar
Nicolai Nygaard Worsøe’s Post
More Relevant Posts
-
#AI is rewriting the narrative for drug discovery. Integrating AI into the process does more than accelerate timelines; it has the potential to foster improvements at every stage with a level of efficiency that was previously unattainable. In our article in Drug Development & Delivery, we explore how the advent of AI is changing the game. https://okt.to/nEQbf1 #AI #Logica #DrugDiscovery
To view or add a comment, sign in
-
In a recent, very popular Anthill webinar, we divide deeper into the current status of AI in pharma and its future. Here's what we found: - Some businesses are watching what happens to AI very closely. - Many are getting their feet wet, running small projects to test the waters. - A few are boldly moving ahead, fully embracing AI’s potential. The whitepaper provides data into what's possible with AI in pharma and offers a snapshot of where the industry stands today and where it's headed. Curious about how your company compares? Discover the key numbers and see how you measure up: https://lnkd.in/dAw_b62g #ai #artificialintelligence #pharma #pharmamarketing
To view or add a comment, sign in
-
#AI in #healthcare is a trending topic, but is it effectively influencing the healthcare sector? Explore the inaugural post of Samarth (Sam) Kashyap 'AI & Healthcare' blog series, where he delves into the misconceptions and excitement surrounding this subject and proposes future directions. #AIinHealthcare #HealthTech #HealthcareInnovation #MedicalAI #HealthcareTechnology #HealthcareTrends #AIImpact #HealthcareFuture #DigitalHealth #HealthcareIT #AIinMedicine #HealthcareTransformation #AIHealthcareSolutions #HealthcareIndustry #EmergingTechnologies #DataDrivenHealthcare #HealthcareAnalytics #AIResearch #FutureofHealthcare #HealthcareInsights
Generative AI is a buzzword that's been floating around lately, but is it truly making an impact in the healthcare industry? Check out the first blog in my 'AI & Healthcare' series where I dive into the myths and hype surrounding this topic and discuss the path forward. Link to the blog: https://lnkd.in/g3fM-A_t #GenerativeAI #AI #Healthcare #Pharma #Innovation #HealthTech
To view or add a comment, sign in
-
Introducing our LinkedIn blog post: "Gen AI - A Boon or Curse for Healthcare & Pharma." In this Part 1 of a multi-part series, our Co-Founder Samarth (Sam) Kashyap talks about how Generative AI technology is reshaping industries, particularly in #healthcare and #pharmaceuticals, by synthesizing data and generating bespoke content. Explore specific applications in clinical trial enrollment, day-to-day analytics, and automation, and learn how AI can revolutionize medical affairs. Join the conversation on the future of AI-enabled healthcare innovation! #GenerativeAI #HealthcareInnovation #Pharmaceuticals #AIinHealthcare Link to the Blog: https://lnkd.in/g3fM-A_t
Generative AI is a buzzword that's been floating around lately, but is it truly making an impact in the healthcare industry? Check out the first blog in my 'AI & Healthcare' series where I dive into the myths and hype surrounding this topic and discuss the path forward. Link to the blog: https://lnkd.in/g3fM-A_t #GenerativeAI #AI #Healthcare #Pharma #Innovation #HealthTech
Gen AI - A Boon or Curse for Healthcare & Pharma
dsdigitalconsulting.com
To view or add a comment, sign in
-
Part 1 of a multi-part series on Generative AI. DSDC co-founder Sam Kashyap dives deeper than the hype, controversies, and shortcomings to explore the value proposition of Generative AI for the #healthcare and #pharmaceutical industry. While some in the tech industry tout it as a cure-all, Sam positions #GenerativeAI as a powerful tool that, if used wisely, can create operational efficiencies across various business functions, from drug compound generation to clinical trials and patient engagement.
Generative AI is a buzzword that's been floating around lately, but is it truly making an impact in the healthcare industry? Check out the first blog in my 'AI & Healthcare' series where I dive into the myths and hype surrounding this topic and discuss the path forward. Link to the blog: https://lnkd.in/g3fM-A_t #GenerativeAI #AI #Healthcare #Pharma #Innovation #HealthTech
Gen AI - A Boon or Curse for Healthcare & Pharma
dsdigitalconsulting.com
To view or add a comment, sign in
-
Is artificial also intellectual? What if subgroups would be excluded from access to innovative healthcare due to the impact of AI? Indeed, AI offers both opportunities and risks related to market access decisions. Our most recent blog can offer a sparkling starting point for an intellectual debate you’re kindly invited for. https://lnkd.in/dDKTBXZe #innovation #pharma.be #ispor
To view or add a comment, sign in
-
Generative AI is a buzzword that's been floating around lately, but is it truly making an impact in the healthcare industry? Check out the first blog in my 'AI & Healthcare' series where I dive into the myths and hype surrounding this topic and discuss the path forward. Link to the blog: https://lnkd.in/g3fM-A_t #GenerativeAI #AI #Healthcare #Pharma #Innovation #HealthTech
Gen AI - A Boon or Curse for Healthcare & Pharma
dsdigitalconsulting.com
To view or add a comment, sign in
-
Harness the power of data with our guide! Explore challenges, strategies, AI integration, and real-world examples in pharma and life sciences. Embrace data democracy today. Read more: https://bit.ly/3zje0zu #DataDemocratization #AI #Pharma #LifeSciences
To view or add a comment, sign in
-
#Drugdiscovery & development is a long, costly, & high-risk process, which takes 10-15 years w/ an average cost of over $1–2 billion for each new drug to be approved for clinical use. #TargetDiscovery combines #knowledgegraph & #AI technology to significantly impact this process. Join our webinar on Thursday to learn about one of the successful implementations of this solution: https://hubs.la/Q02kGDsj0
To view or add a comment, sign in
-
Read Lifebit's latest blog on uncovering innovative strategies to enhance recruitment and enrolment in clinical trials. Addressing significant challenges in drug development, this blog explores how AI, machine learning and digital tools streamline processes, reduce costs and expedite drug approvals. Gain a deeper understanding of these advancements and their transformative potential: https://bit.ly/4eMTCH4 #ClinicalTrials #PatientEngagement #Diversity #HealthTech #Lifebit
To view or add a comment, sign in